NYSE - Delayed Quote
USD
Johnson & Johnson (JNJ)
275.23
-3.20
(-1.15%)
At close: September 4 at 4:00:02 PM EDT
278.51
+3.28
(+1.19%)
After hours: September 4 at 7:59:34 PM EDT
Trade JNJ on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreAnalyst Insights
Top Analyst
UBS
59/100
Analyst Price Targets
Analyst Recommendations
-
Strong Buy
-
Buy
-
Hold
-
Underperform
-
Sell
Latest Rating
Date
9/2/2026
Analyst
UBS
Rating Action
Maintains
Rating
Buy
Price Action
Raises
Price Target
280 -> 320
Top Analysts
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more| Analyst
|
Overall Score
|
Direction Score
|
Price Score
|
Latest Rating
|
Price Target
|
Date
|
|---|---|---|---|---|---|---|
|
UBS
|
59 | 66 | 86 | Buy
|
320 | 2026-09-03 |
|
RBC Capital
|
57 | 60 | 100 | Outperform
|
287 | 2026-07-16 |
|
Citigroup
|
53 | 55 | 100 | Buy
|
298 | 2026-07-08 |
|
Raymond James
|
49 | 47 | 100 | Outperform
|
265 | 2026-07-16 |
|
Wells Fargo
|
48 | 47 | 78 | Overweight
|
282 | 2026-08-04 |
|
Guggenheim
|
47 | 38 | 78 | Buy
|
287 | 2026-08-07 |
|
Goldman Sachs
|
41 | 35 | 79 | Buy
|
240 | 2025-12-19 |
|
Barclays
|
37 | 24 | 92 | Equal-Weight
|
255 | 2026-04-15 |
|
Morgan Stanley
|
37 | 19 | 100 | Overweight
|
294 | 2026-07-17 |
|
Bernstein
|
35 | 24 | 59 | Market Perform
|
208 | 2026-01-09 |
Rows per page
1-10 of 13
Upgrades & Downgrades
| Maintains | UBS: Buy to Buy | 9/2/2026 |
| Maintains | Guggenheim: Buy to Buy | 8/6/2026 |
| Maintains | Wells Fargo: Overweight to Overweight | 8/3/2026 |
| Reiterates | Guggenheim: Buy to Buy | 7/17/2026 |
| Maintains | Raymond James: Outperform to Outperform | 7/16/2026 |
| Reiterates | RBC Capital: Outperform to Outperform | 7/16/2026 |
